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Background. Duchenne Muscular Dystrophy (DMD) is characterized by increased muscle damage and an abnormal blood flow
after muscle contraction: the state of functional ischemia. Until now, however, the cause-effect relationship between the
pathogenesis of DMD and functional ischemia was unclear. We examined (i) whether functional ischemia is necessary to cause
contraction-induced myofiber damage and (ii) whether functional ischemia alone is sufficient to induce the damage.
Methodology/Principal Findings. In vivo microscopy was used to document assays developed to measure intramuscular red
blood cell flux, to quantify the amount of vasodilatory molecules produced from myofibers, and to determine the extent of
myofiber damage. Reversal of functional ischemia via pharmacological manipulation prevented contraction-induced myofiber
damage in mdx mice, the murine equivalent of DMD. This result indicates that functional ischemia is required for, and thus an
essential cause of, muscle damage in mdx mice. Next, to determine whether functional ischemia alone is enough to explain the
disease, the extent of ischemia and the amount of myofiber damage were compared both in control and mdx mice. In control
mice, functional ischemia alone was found insufficient to cause a similar degree of myofiber damage observed in mdx mice.
Additional mechanisms are likely contributing to cause more severe myofiber damage in mdx mice, suggestive of the existence
of a ‘‘two-hit’’ mechanism in the pathogenesis of this disease. Conclusions/Significance. Evidence was provided supporting
the essential role of functional ischemia in contraction-induced myofiber damage in mdx mice. Furthermore, the first
quantitative evidence for the ‘‘two-hit’’ mechanism in this disease was documented. Significantly, the vasoactive drug
tadalafil, a phosphodiesterase 5 inhibitor, administered to mdx mice ameliorated muscle damage.
Citation: Asai A, Sahani N, Kaneki M, Ouchi Y, Martyn JAJ, et al (2007) Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit
Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular Dystrophy. PLoS ONE 2(8): e806. doi:10.1371/journal.pone.0000806
INTRODUCTION
Duchenne Muscular Dystrophy (DMD) is caused by the lack of
a gene product, dystrophin [1], and affects approximately one in
3,500 male births [2]. The skeletal muscles of DMD patients
undergo slow progressive damage which leads to the onset of the
disease. The precise pathophysiology is not known except for the
widely accepted theory that membrane vulnerability inherent to
DMD muscles plays a role [3].
Previous studies demonstrated that lack of dystrophin and its
associated molecules were found to cause a defect in blood flow
response in the muscle tissues [4,5]. In response to contractile
workload, normal muscles endeavor to increase the blood flow to
meet the muscular metabolic demands [6]. However, when this
response in blood flow is attenuated, the muscles are put under the
risk of ischemia due to a lack of either sufficient supply of oxygen
and nutrients or sufficient drainage of the accumulated metabo-
lites, the pathological state of ‘‘functional ischemia’’ [4,7].
Ischemia is defined as the state of blood flow decrease due to
structural vascular obstruction or vasoconstriction. Functional
ischemia is a status where blood flow cannot match the metabolic
demand of tissues even in the absence of vascular obstruction. The
balance between the demand and supply of blood flow is disturbed
in both cases.
Nitric oxide (NO), a.k.a. endothelium-derived relaxing factor
(EDRF), produced in skeletal muscles controls local blood flow in
the muscle [8,9] along with various other vasoregulatory
molecules. In patients with DMD [4] as well as mdx mice (the
murine equivalent) [5,10], the sarcolemmal expression of neuronal
type nitric oxide synthase (nNOS) in skeletal muscle is greatly
reduced with a concomitant aberration in blood flow regulation.
Various studies have reported vascular pathology [11–16],
altered vasodilative response [17,18], and disturbed vasodilative
signaling downstream of nNOS [10]. What has not been
evaluated in detail, however, is whether blood flow dysregulation
due to lack of nNOS expression is a primary cause or a secondary
defect of muscular dystrophies. Since nNOS knock-out mice
showing similar blood flow abnormality [5] do not manifest
phenotypes of muscular dystrophy [19,20], it has been suggested
that functional ischemia or lack of nNOS may be an auxiliary
event but not a direct cause of the disease. Lack of a dystrophic
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more than that nNOS absence or blood flow abnormality is
insufficient to cause muscular dystrophy. It is inaccurate to
conclude that nNOS absence or disturbed circulation is not an
essential cause of the disease. In addition to NO, tissues produce
other types of vasodilatory factors, including endothelium-derived
hyperpolarizing factor (EDHF) [21]. Although the identity of
EDHF remains elusive, previous reports demonstrated that
superoxide dismutase (SOD) produces hydrogen peroxide
(H2O2), which exert EDHF-like functions [22]. Furthermore, it
was previously proposed that a single factor is not enough to
explain the pathogenesis of DMD and hypothesized that at least
two factors are necessary to induce myofiber damage: the ‘‘two-
hit hypothesis’’ in DMD [23].
In this study blood flow regulation in the pathogenesis of
muscular dystrophy was evaluated using in vivo microscopic assays:
we examined how blood flow responds to muscle contraction in
mdx and control mice, whether NO/H2O2 production in muscles
is attenuated in mdx mice, and whether augmenting the nitric
oxide pathway can prevent functional ischemia and the myofiber
damage in mdx mice. The extent of functional ischemia and the
amount of myofiber damage were compared in both mdx and
control mouse models. The phosphodiestease-5 inhibitor, tadalafil,
a known vasodilator, was evaluated and found to be a therapeutic
agent to reduce muscle damage.
RESULTS
Control mice show a contraction-induced increase in
RBC flux in muscles that is deficient in mdx mice
Various parameters exist for the analysis of local blood flow,
including RBC flux, RBC velocity, plasma flow, blood vessel
diameter and functional capillary density. Among these, RBC
flux reflects local oxygen supply [24] and is a well established
standard method to evaluate local blood flow. In this study, we
measured the peripheral RBC flux at the intramuscular primary
arterioles under in vivo conditions (for nomenclature of blood
vessels, see supporting information, Figure S1). Observation of
fluorescent RBC labeled by various dyes including PKH26GL is
a well accepted method for analyzing microcirculation. To assess
a possible influence of fluorescent labeling of the RBC by
PKH26GL on the flow dynamics of RBCs, an alternative
staining method (FITC) was used; the same pattern of kinetics
(data not shown) was obtained, indicating there was no
significant effect of the fluorescent staining. The basal level of
the absolute crude RBC flux (stained and non-stained RBCs
combined) were 8043.261372.5 and 10403.261876.0 for
control and mdx mice (flux count per minute6S.E., N (numbers
of animals)=18 and 17, not statistically different, p=0.31 by t-
test). The validity of our labeling method is thus assured by the
consistency with the previous studies reporting RBC flux at
venules (12–39 mm in diameter, presumably secondary to
tertiary venules) of c.a. 100,000 per minute in mice [25], and
resting capillary flux of 1,800 or 1200–2000 per minute in rats
[26] or in hamsters [27] (note that one primary arteriole feeds
several capillaries and dozens of capillaries feed into secondary
venules).
As shown in Figure 1a, control mice showed an increase in RBC
flux that persisted for over 8 to 10 minutes in response to
contraction by 50 Hz tetanic stimulation. There were no essential
differences in the pattern of RBC flux change between NMJ and
non-NMJ areas in either strain of mice except for a slight
difference in the time-course of RBC flux increase in control mice.
Thus, all measurements were performed in non-NMJ areas
hereafter unless otherwise specified. In previous experiments, high
frequency stimulation at 20Hz on rat hindlimb muscles caused an
increase in blood flow velocity lasting up to 14 minutes after the
cessation of stimulation [28], corresponding well with our result.
Direct stimulation on one side of the sternomastoid muscle did
not evoke contraction on the other side, and the RBC flux in the
contralateral side of the muscle remained at the basal level
(Figure 1a). This observation suggests that under the conditions
utilized in this study, the stimulus on the sternomastoid muscle did
not alter the cardiac output, and the increase of blood flow was
specific to the local stimulation of the muscle.
The mdx mouse experiments showed a total absence of increase
of RBC flux after tetanic stimulation both in NMJ and non-NMJ
areas (Figure 1b) despite the fact that the tetanic stimuli yielded
a similar extent of muscle contraction in mdx and control mice
(Figure S2, supporting information). To examine whether the lack
of response in mdx mice was due to the defect in blood vessels or to
the defect in the signal transmission between muscles and blood
vessels, we applied SNAP (S-nitroso-N-acetylpenicillamine, NO
donor) locally. When SNAP was given to the resting muscles in mdx
mice, the RBC flux was increased to a maximum of 212.4% of basal
flux (Figure 1b). This increase was comparable to changes in control
mice administered with the same dose of SNAP (data not shown,
maximum increase up to 236.2%, N (numbers of animals)=10, not
significantlydifferentfrommdxmiceatanytimepointbetween0and
8 minutes). This result suggested that vasodilatory mechanisms in
the blood vessels were functional in the mdx mice but the signaling
between skeletal muscles and blood vessels was compromised. A
furtherconfirmationofthisfindingwas observed when a membrane
permeable cGMP analogue, 8-(4-Chlorophenylthio)-guanosine 39,
59-cyclic monophosphate (8-CPT cGMP) was locally applied. This
drug caused a slow increase in the RBC flux in mdx mice, reaching
a similar extent of response to that seen in the SNAP group by
7 minutes after administration. Given that the vasodilatory effect of
NO is through a cGMP-dependent pathway [29–31], the difference
in the kinetics of RBC flux increase between groups with SNAP and
with 8-CPT cGMP is likely due to the difference in the speed of the
drugs to reach their target cells. The effect on RBC flux increase by
8-CPT cGMP is not a non-specific irreversible vaso-action, but is
likely a specific physiological regulation, because this response was
completely antagonized by a further addition of physiological
concentration of a vasoconstrictor, angiotensin-II (ATII). Because
b2-adrenergic agonists have a different mechanism of vasodilation
that does not involve NO [32], we examined whether clenbuterol
causes vasodilation in mdx mice. When clenbuterol was locally
administered instead of SNAP, mdx mice showed an increase in
RBC flux, albeit to a lesser extent (maximum up to 172%,
Figure 1b). The result from the clenbuterol experiment confirms
that the mechanism of vasodilation inherent to the vascular smooth
muscle is functional in mdx mice.
Nitric Oxide and hydrogen peroxide production in
response to muscle contraction is attenuated in mdx
mice
In vivo production of vasodilatory molecules (i.e. NO and H2O2) was
measured in the sternomastoid muscles in mdx and control mice to
investigate the mechanisms for functional ischemia in mdx mice.
Direct tetanic stimulation on the sternomastoid muscle induced
a marked elevation in the level of NO in the myofibers (Figure 2
a&b). When L-NAME (Nv-Nitro-L-arginine methyl ester), a non-
specific NOS inhibitor, was applied, production of NO from muscle
fiberswasreduced byapproximately67.6%ofthe netincrease.This
result demonstrated that the majority of the detected fluorescent
Functional Ischemia in Mdx
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applied L-NAME cannot suppress all the intracellular NO
production is consistent with previous studies [33]. The effects of
muscle contraction on NO production between control and mdx
mice were compared (Figure 2 a&b). The basal level of NO in the
resting muscle of mdx mice was higher than control mice, but the
increase in the NO production after muscle contraction was
completely abolished in mdx mice. Production of NO from non-
myofiber cells was noted(black and whitearrow heads in Figure 2a).
Although the identity of EDHF has not been fully confirmed,
previous studies demonstrated the production of hydrogen
peroxide (H2O2), detected by the fluorescence of carboxy-H2-
DCFDA (29,79- dichloro-dihydrofluorescein diacetate), has the
EDHF-like function [22]. In this study, H2O2 production in the
sternomastoid muscle was compared between control and mdx
mice by using carboxy-H2-DCFDA. Direct tetanic stimulation on
the muscle induced the production of H2O2 inside the myocytes in
the control mice (Figures 2a&c). It is well established that
pharmacological agents, including the combination of apamin
and charybdotoxin [34], inhibit EDHF by antagonizing calcium
activated potassium channels on vascular endothelial cells in ex vivo
experiments [34,35]. The production of H2O2 by myofibers was
inhibited by the combined application of apamin and charybdo-
toxin to the muscle superfusative solution (Figures 2a right 3rd
panel, 2c 3rd column). The increase in the amount of H2O2
detected after tetanic stimulation was attenuated in the mdx mice
(Figures 2a right bottom panel, 2c far right column). These
experiments demonstrate that in the sternomastoid muscle of
control mice, both NO and H2O2 are increased after tetanic
stimuli, while in mdx mice tetanic stimulation fails to increase the
production of both molecules, a potential cause of the disturbed
regulation of RBC flux.
Pharmacological reversal of functional ischemia
prevents exercise-induced myofiber damage in mdx
mice
Experiments were designed to determine whether improvement of
microcirculation by replenishing NO in mdx mice (Figure 1b) can
prevent muscle contraction-induced cell death. Using DiOC6,
a membrane potential-dependent dye that is incorporated into
mitochondria and endoplasmic reticulum (M/ER) only in live cells
(Figure 3a), we followed the chronological change in the
morphology of myofibers in vivo and counted the number of
damaged myofibers. An advantage of this technique is that fibers
already dead before treatments are not stained (Figure 3b), while
fibers damaged after the staining can be detected (Figure 3c).
Thus, it became possible to evaluate the specific effect of muscle
contraction and/or pharmacological intervention.
Intact muscle fibers showed a green fluorescent signal of clusters
of M/ER in a striated pattern (Figure 3a). For quantification of
myofiber damage, we counted numbers of damaged loci (locus)
instead of numbers of the damaged fibers, because there are
different types of damage observed along the length of a myofiber
(see Methods for detail). Dying muscle fiber loci both in control
(Figure 3c) and mdx (not shown) mice revealed a disturbed
intracellular distribution pattern of the green fluorescence. Cell
death was confirmed by dye-exclusion staining (endpoint blue
color in Figure 3) and annexin-V staining (Figure S3, supporting
information). This result from our in vivo study confirms earlier
morphological analyses of mitochondrial abnormality in skeletal
muscle cell death observed in toxin-induced [36,37] and muscular
dystrophy [38] mouse models. The myofiber loci with signs of
damage (granular, ripple, and bulged staining by DiOC6) never
returned to the normal striated staining after a prolonged time-
lapse observation up to 12 hours. The morphological changes
stated above are considered irreversible and myofiber loci
manifesting these characteristics are indeed dying (for criteria of
fiber loci counting, see supporting information, Figure S4a&b).
The staining procedure did not affect muscle viability and intact
myofibers retained their normal striated pattern of M/ER during
the time of observation (Figure 3a).
Tetanic stimulation (6 times repeat, 5 seconds duration at
50 Hz) induced progressive myofiber damage in the mdx mice
(Figure 4, open circle and black line, ‘‘mdx’’), consistent with
previous reports of mechanical weakness of the myofibers from
muscular dystrophy subjects [39]. At 6 hours after tetanic
stimulation, 67.6766.57 (count6S.E.) myofiber loci were dam-
aged out of the entire field of observation. The total numbers of
loci was 350 to 400 (70 to 80 myofibers scanned 5 times).
We evaluated whether reversal of functional ischemia can
attenuate this contraction-induced myofiber damage. As demon-
strated in Figure 1b, an NO donor, SNAP, can improve muscle
blood flow in mdx mice. When SNAP was locally applied to mdx
mice during muscle contraction cell death was completely
abolished (Figure 4, open square and red dash-dotted line,
‘‘mdx+NO’’). Microscopic images of these experiments are pro-
vided in Figure S5a (supporting information).
These observations from the SNAP experiments support the
hypothesis that functional ischemia is necessary and plays a primary
role in contraction-induced myofiber damage in mdx mice and can
be prevented by augmentation of NO. To further investigate
whether this cytoprotective effect involves a cGMP-dependent
pathway, the effect of 8-CPT cGMP was examined in the same cell
death experiment since this drug increases RBC flux in mdx mice
(Figure 1b). The contraction-induced myofiber damage was
successfully prevented (Figure 4, closed diamond and blue dash-
dot line). The myofiber protective effect by 8-CPT cGMP was likely
mediated by its vasoregulatory potential, because this beneficial
response was completely inhibited when ATII was further added at
the concentration that antagonized the increase in RBC flux
(Figure 4, open diamond with blue dash-dot line). The inhibitory
effect by ATII on cGMP-mediated cytoprotection is likely through
the vascular regulation, but not by its direct catabolic function on
myofibers, because ATII alone did not have a cytotoxic effect on
myofibers (Figure 4, open diamond with light-blue dash line). When
the b2-adrenergic agonist clenbuterol was locally administered
instead, before and during tetanic stimulation, contraction-induced
myofiber damage was attenuated (Figure 4, closed diamond and
green solid line) although b2-adrenergic agonists are known to have
different vasodilatory mechanisms from NO/EDHF [32]. Since
previous studies reported elevated PDE5 activity in the skeletal
muscle samples from mdx mice [40] and decreased cGMP
production [10], we hypothesized that administration of PDE5
inhibitor will increase the amount of cGMP, and therefore prevent
myofiber damage as predicted from the data with 8-CPTcGMP.
Tadalafil (4 mg/kgBW ) was applied to the mdx mice via a gastric
tube 60 minutes before the start of tetanic stimulation. Adminis-
tration of tadalafil lowered the amount of myofiber damage
(Figure 4, cross mark and orange solid line). Placebo treatments
did not prevent the myofiber damage (data not shown).
Is functional ischemia sufficient to cause
contraction-induced myofiber damage?
Experiments were designed to evaluate whether skeletal muscle cell
death similar to those observed in mdx mice can be simulated by
inflicting artificial functional ischemia on the wild-type animals.
Functional Ischemia in Mdx
PLoS ONE | www.plosone.org 3 August 2007 | Issue 8 | e806Figure 1. Local RBC flux is increased in the post-contraction muscle of control but not of mdx mice. Using in vivo video-microscopy, the numbers
of RBC passing by through the primary arterioles (1st order) in control (a) and mdx (b) mice were counted and plotted against time (minutes) after
a tetanic stimulation (50Hz). The y-axis represents the percent increase in the RBC number from the basal (100%) RBC flux. (a) In response to the direct
tetanic stimulation on the muscles of control mice, arterioles both at junctional (NMJ, closed square, red solid line), and extrajunctional (non-NMJ,
open circle, black solid line) areas showed a transient increase in the RBC. The contralateral side of the control mice (closed triangle, dash-dotted line)
Functional Ischemia in Mdx
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charybdotoxin (inhibition of EDHF), and vascular oppression was
given concomitantly, a twelve-times repeat of tetanic stimuli
produced 56.2613.69 (count6S.E.) damaged myofiber loci at
6 hours post tetanic stimulation (closed diamond and black line in
the Figure 5). Comparable myofiber damage was not observed in
the absence of any one of the following reagents/interventions: L-
NAME (Figure 5, open square and red dotted line), apamin plus
charybdotoxin (closed triangle and blue line), vascular oppression
(open diamond and orange dotted line), or tetanic stimulation
(closed square and pink line). Tetanic stimulation and vascular
oppression alone did not cause prominent myofiber damage (open
Figure 2. In vivo microscopic measurement of muscle production of NO and H2O2 in control and mdx mice after tetanic stimulation. (a) In vivo
microscopic views of fluorescent signal (1006) are presented with pseudocolors added according to the fluorescent intensity of the signals (a).
Warmer colors correspond to higher intensity (note scale bar on right side). NO or H2O2 produced by stimulated myofibers reacts with DAF-FM (left
column) or H2-DCFDA (right column) respectively, and releases a fluorescence signal. The longitudinal area between the two black arrows in the
microscopic image corresponds to an individual myofiber (row1, Cont, no Stim). Myofibers in the control muscles produce a prominent amount of NO
(left) and H2O2 (right) in response to tetanic stimuli (50Hz), shown as Cont, Tet (row 2). The spot-like staining showed an increased production of NO
in response to muscle contraction (‘‘Cont, Tet’’ in the left column, examples pointed by a black arrow head), but were not prominent with H2O2 signal
(right column). A non-specific NOS inhibitor L-NAME (row3, left), or combination of EDHF inhibitors apamin and charybdotoxin (row 3, right),
perturbed production of NO or H2O2, respectively, after tetanic stimulation (Cont, Tet+Inhibitors). Although the basal level of NO production in the
mdx muscle is high (row 4, left column, Mdx, no Stim, p=0.004 by Student-t test), muscles in these mice do not show an increase in the NO (row 5,
left) or H2O2 (row 5, right) production in response to muscle contraction (Mdx, Tet). Mdx mice showed greater numbers of spot-like staining for NO
(examples pointed by a white arrow head) as compared to control mice, but these spots did not show an increase in intensity after muscle
contraction. (b&c) The quantification data of the detected signal of NO (b) and H2O2 (c) in the sternomastoid muscles are shown. Average
fluorescence released by myocytes was calculated by densitometry of the captured images from in vivo microscopy on different mice (the numbers of
animals in each group indicated in the bottom row). The y-axis represents the percent increase in the arbitrary fluorescence unit per 30 (b) or 60 (c)
minutes of observation. **: Statistically significant by ANOVA (P,0.01). n.s.: Not statistically significant. #: Statistically significant between the basal
level of control and mdx mice (P,0.05). Error bars show standard error of each value.
doi:10.1371/journal.pone.0000806.g002
r
did not show any increase in the RBC flux, suggesting that the increase in RBC flux is the specific effect of contraction. (b) The response in RBC flux
was completely absent in mdx mice (NMJ: closed square, red solid line, and non-NMJ: open circle, black solid line). RBC flux was increased in mdx mice
by a local administration of SNAP (open square, red dash-dotted line), clenbuterol (closed diamond and greed solid line), or 8-CPT cGMP (closed
diamond and blue dash-dotted line). Addition of 1 mg/ml of angiotensin-II (ATII) inhibited the 8-CPT cGMP-induced increase in RBC flux (open
diamond, blue dash-dotted line). Addition of ATII transiently dropped the RBC flux below 50% of the basal level and the values (1.1% for 1min and
17.4% for 2 min) are indicated as numbers adjacent to each point. Unless otherwise specified, measurements were performed on arterioles in non-
NMJ areas. ** and ***: Statistically significant difference from contralateral side in control mice (a) or from mdx mice without any treatment (b) by
ANOVA (p,0.01, p,0.001, respectively). n.s. Not significantly different from contralateral side by ANOVA (a). # and ##: Statistically significant
difference (p,0.05 and 0.01) between NMJ and non-NMJ by Student-t test (a). Standard errors are shown as bars at each time point. The number of
individual animals in each group is indicated in the parenthesis.
doi:10.1371/journal.pone.0000806.g001
Functional Ischemia in Mdx
PLoS ONE | www.plosone.org 5 August 2007 | Issue 8 | e806circle and green dotted line). A six time repeat of tetanic stimuli
caused less amount of myofiber damage (21.6066.52 (count6S.E.)
loci at 6 hours, cross and cyan dash-dotted line). Detailed
microscopic images of each group are provided in the Figure S5b
(supporting information). Our pharmacological intervention did not
revert the abnormal fragmented morphology of NMJs in mdx mice
(Figure S5a, red staining) to normal pretzel-like shape (Figure S5b),
or vice versa in control mice, during the 6 hours of observation.
The amount of functional ischemia achieved by various
treatments were quantified by integrating the total change of
RBC flux during the 10 minutes after tetanic stimulation (calcula-
tions shown in supporting information, Figure S6) to evaluate
whether functional ischemia alone was enough to explain the
contraction-induced myofiber damage in mdx mice. Functional
ischemia is defined as a pathological state when there is a lack of
normal response in blood flow in post-contraction muscles: in our
experiment, mdx mice did not show an increase of RBC flux in
response to tetanic stimulation (Figure 6, far right column).
Treatment of control mice with L-NAME, apamin plus charybdo-
toxin, or vascular oppression individually caused functional
ischemia to a similar extent observed in mdx mice, but caused
a larger decrease in RBC flux when all werecombined (Figure 6). In
the case where the combination of treatments caused a significant
drop in RBC flux, such a pathological state fits in the definition of
‘‘severe ischemia’’, and not functional ischemia. Theoretically,
a complete obstruction of the arteriole under observation will result
in the value of negative 950. In our experiments, the severest
ischemia we observed had a value of negative 537 (Figure 6, all drug
combination, 2nd column from right) and still maintained a certain
level of blood flow. These experiments suggest that functional
ischemia alone is not enough to cause myofiber damage.
Vascular therapy with tadalafil,
a phosphodiesterase-5 inhibitor
To test the hypotheses that (i) preventing myofiber degeneration
can impede the progress of muscular dystrophy and that (ii) agents
targeted towards the NO-cGMP pathway can be used as
therapeutic candidates, mdx mice were treated with orally
administered tadalafil, a phosphodiesterase-5 inhibitor (PDE5I).
This drug increases intracellular levels of cGMP in the vascular
smooth muscle cells, causes vasodilation and increases blood flow
to the target organ. Without treatment, mdx mice showed an
increased amount of damaged myofibers in hindlimb and
diaphragm as revealed by their blue color after Evans Blue dye
injection (Figure 7a, top 6 panels, and Figure 7b, top 3 panels).
When mdx mice were treated with tadalafil, the amount of dying
fibers was decreased (Figure 7a, bottom 6 panels and Figure 7b,
Figure 3. In vivo microscopic assay of myofiber damage. Identical positions of the myofibers were traced by examining the anatomy of the
individual myofibers (stained green), and/or the shape and relative location of NMJs (stained red by BTX-Alexa Fluor 594). (a) Intact cells in control
mice with no treatment showed a normal striated pattern of staining of M/ER with DiOC6 (Intact myofibers, control mouse#1). (b) Already dead
myofibers (killed by electrical ablasion 1 hour before the experiment) are not stained and excluded from the study. (c) When cells are induced to
death by combination of severe ischemia (L-NAME, apamin, charybdotoxin, and vascular oppression) and strenuous contraction (12 times repeat of
tetanic stimuli), distribution of these DiOC6-stained compartments becomes granular (arrow heads) or bulged (arrows), or exhibit a rippled pattern
(asterisk). Each image is in focus. Cell death identified by abnormal DiOC6 labeling was confirmed by dye-exclusion staining with short exposure to
Hoechst33258 (blue color at endpoint in each group). The black scale bar in the figure represents 10 mm.
doi:10.1371/journal.pone.0000806.g003
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mice were sectioned and evaluated under fluorescence microsco-
py, mdx mice without treatment showed an increased red-
fluorescent staining while exposure with tadalafil diminished the
injury in the gastrocnemius, gluteus maximus, quadriceps, and
diaphragm muscles (Figure 7c&7d). To further confirm this
finding, conventional histology with trichrome and hematoxylin-
eosin (H&E) staining (Figure 8a) was performed on both tadalafil-
treated and non-treated mdx mice. The extensive myofiber damage
and ectopic fibrosis (Figure 8a, blue deposit in the interstitial area
in trichrome staining, yellow arrows) was prominent in non-treated
mdx mice. The extent of ectopic fibrosis was decreased by tadalafil
treatment (Figure 8b for quantification, p,0.05). The numbers of
myofibers with central nuclei was reduced by tadalafil treatment
(Figure 8c). The variation in fiber size prominent in non-treated
mdx mice, was reduced by tadalafil treatment (Figure 8d, p,0.05).
These data suggest that myofiber protective effect by tadalafil can
slow down the progress of the disease.
DISCUSSION
Functional Ischemia is likely an essential cause of
muscular dystrophy
The still unsettled debate over the role of blood flow regulation in
DMD was initiated as early as the mid-19th century. The most
important question remaining is whether disturbed circulation in
skeletal muscles plays a primary role in the pathogenesis of DMD.
Using newly established assays to follow in vivo myofiber cell death,
combined with microcirculation analyses, we have documented
evidence that supports the essential role of vasoregulation in the
pathophysiology of the skeletal muscles in mdx mice and have shown
that therapeutic drugs targeted towards vasoregulation are effective
in decreasing myofiber damage in these mice. This finding is
consistent with previous reports that transgene overexpression of
nNOS in mdx mice [41,42] or dystrophin in their vascular smooth
muscle cells [43] ameliorated the muscle damage. The transgenic
expression studies of nNOS in mdx mice utilized a skeletal muscle
specific promoter [41,42], and provided the basis for an assertion
that nNOS protects myofibers by directly working on myofibers.
However, NO is a secretable molecule, and increasing evidence
support that NO is utilized in intercellular communication [44,45].
Thus, the previous studies have notexcluded the possibility that NO
produced from myofibers protect myofibers by acting on vascular
regulation. Past reports support that nNOS expression in myofibers
control the vasodilation in skeletal muscles [8].
The ‘‘functional ischemia’’ theory of muscular dystrophy
demonstrated that under the stress of vasoconstrictors, the
patients’ muscles are unable to increase blood flow back to
normal even after muscle contraction [4,5]. A major innovation
and strength of this current investigation measuring the peripheral
Figure 4. Replenishing NO prevents contraction-induced myofiber cell death. Mdx mice (open circle and black solid line, N=6) showed progressive
increase of damaged loci over the time course of 6 hours after a 6 times repeat of the tetanic stimuli (X-axis: time after tetanic contraction. Y-axis:
damaged myofiber loci counted throughout the entire tissue). For quantification of myofiber damage, the numbers of damaged sites (loci) were
counted instead of numbers of the damaged fibers, because there are various types and different locus onset of damage along the length of
a myofiber (see Methods for detail). Administration of SNAP (NO donor, 100 mM) prevented the mdx mice fibers from undergoing contraction-
induced damage (open square and red dash-dotted line, N=5). In the groups where 8-CPT-cGMP (‘‘cGMP’’, 500 mM, closed diamond and blue dash-
dotted line, N=5), clenbuterol (‘‘Clen’’, 0.05 mg/ml, closed diamond and green solid line, N=4), or tadalafil (‘‘Tada’’, 4 mg/kgBW, cross and orange
solid line, N=5) was given during muscle contraction, the increase in myofiber damage was abolished. Addition of 1 mg/ml of angiotensin-II (ATII)
inhibited the myofiber protective effect by 8-CPT-cGMP (open diamond and blue dash-dotted line, N=6). ATII alone did not cause myofiber damage
(open diamond and blue dotted line, N=4). Control mice with (closed triangle and blue solid line, N=4) or without (open triangle and pink solid line,
N=6) SNAP administration did not show increase in myofiber damage. Statistical differences are indicated between mdx without drug treatment
(black open circle) and all other groups except for 8-CPT cGMP plus ATII (**: p,0.01, ***:p,0.001), or all other groups except for 8-CPT cGMP or 8-CPT
cGMP plus ATII (++:p ,0.01) by ANOVA. There was a statistically significant difference between groups with 8-CPT cGMP and with 8-CPT cGMP plus
ATII (#:p ,0.05, ##:p ,0.01) by Student-t test. There was no significant difference between groups without any treatment (black open circle) and
with 8-CPT cGMP plus ATII (blue open diamond) at any time point. Error bars in the graph are the standard errors to each value. All the drugs are
removed and tissues are washed after muscle contraction. N refers to the number of animals used for each treatment.
doi:10.1371/journal.pone.0000806.g004
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scheme of stimulation than those utilized in previous macroscopic
studies, enabling simple and quantitative discussions (Figure S7,
supporting information).
Until now, one of the technical limitations of cell death studies
came from the fact that myofiber cell death is always increased in
the muscles of muscular dystrophy subjects (see Figures 7 abc&d).
With conventional assays, there is considerable amount of cell
death even before pharmacological/molecular interventions are
applied, masking the effect by interventions even if they induce
further cell damage. Our new method of myofiber cell death
eliminated the already dead cell population by using a membrane
potential-dependent dye, DiOC6, which is incorporated only by
live cells at the beginning of experiment. This new approach
enabled quantification of the specific effect of physiopharmacolo-
gical interventions and allowed simple and clear discussions.
By using direct observation of the live animals, we documented
a complete lack of the stimulated production of two vasodilative
molecules, NO and H2O2, in response to muscle contraction:
a possible cause of functional ischemia. Detailed observation
detected a slightly elevated basal level of NO production in mdx
mice, and its release from non-myofiber type cells (Figure 2).Sinceit
is known that the sarcolemmal expression of nNOS is lost in mdx
mice [46], and activity [47] and expression level [4] of eNOS is
unchanged in the cardiac and skeletal muscles of mdx mice or DMD
patients, the high basal level of NO is likely from upregulated
expression of inducible NOS (iNOS) [48]. Further experiments are
required to confirm this notion. By replenishing NO to the
myofibers of mdx mice, blood flow to muscle was improved and
contraction-induced myofiber damage was prevented (Figure 4).
The same finding was confirmed by application of clenbuterol or 8-
CPTcGMP.Myofiberprotectionby8-CPTcGMPislikelythrough
a vascular control, because its benefit was completely abolished by
furtheradditionofATII at the vasoconstrictive dose.Thisinhibitory
effect of ATII is likely through vascular regulation, but not its direct
catabolic function on myofibers, because ATII alone did not cause
myofiber damage. These experiments suggested the primary role of
functional ischemia in contraction-induced myofiber damage in mdx
mice. Functional ischemia is necessary as a cause of contraction-
induced myofiber damage.
Possible involvement of the other vasodilator, EDHF
Previous studies on EDHF were predominantly performed on
vascular systems and to a lesser extent on skeletal myocytes. There
have been many confounding opinions as to the identity of EDHF,
its generation site, its action site, its existence as (a) secretable
molecule(s), and involvement of gap-junctions, to name a few,
leading to our putative understanding that EDHF is a heterogenic
entity of vasodilative molecules/factors whose behavior is variable
depending on the tissues of study. The action site of apamin and
charybdotoxin, two well-established pharmacological inhibitors of
EDHF, has also been controversial until recently. Previously, they
were considered to work at the very downstream of EDHF
function by inhibiting the hyperpolarization of vascular smooth
muscle cells. In ex vivo vascular experiments, however, increasing
evidence [34,35] suggests that apamin and charybdotoxin work on
endothelial cells (upstream), rather than on vascular smooth
muscle cells (downstream). Our finding suggests that skeletal
Figure 5. Severe ischemia induced by pharmacological interventions results in myofiber damage in control mouse receiving repeated tetanic
stimulation. Numbers of damaged myofiber loci (y-axis) were counted throughout the entire tissue using in vivo microscopy and plotted against
time after tetanic contraction (x-axis). For quantification of myofiber damage, the numbers of damaged sites (loci) were counted instead of numbers
of the damaged fibers, because there are different types of damage observed along the length of a myofiber (see Methods for detail). When ischemia
stress was provided by applying L-NAME, apamin plus charybdotoxin (ChTx), and vascular oppression, control mice showed progressive increase in
the amount of muscle damage (closed diamond and black solid line) under the application of increased stimuli (12 times). However, when L-NAME
(open square and red dotted line), apamin plus charybdotoxin (closed triangle and blue solid line), or vascular oppression (open diamond and orange
dotted line) was lacking, a comparable amount of myofiber injury was not achieved. Even when all reagents were present, the amount of myofiber
damage was minimal without tetanic contraction (closed square and pink solid line). Tetanic stimulation and vascular oppression alone did not cause
significant myofiber destruction (open circle and green dotted line). Six times stimuli applied in control mice (X mark and blue dash-dotted line) did
not induce an equivalent amount of myofiber damage as compared to 12 times control (black diamond) or to 6 times mdx mice (Figure 4, open black
circle). N=5 mice for each treatment. *:p,0.05, **:p,0.01, by ANOVA. Standard errors are shown as bars added to each point.
doi:10.1371/journal.pone.0000806.g005
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EDHF, in concert with NO, may function to convey signals for
musculo-vascular communication, though whether the detected
H2O2 is an EDHF has to be confirmed.
The reason for the prominent production of fluorescence signals
from non-myocyte (non-fiber-like, dotty staining) only in assays for
NO (Figure 2a, the first and second columns, arrows) but not in
those for H2O2 (the third and fourth columns) may be in part
because infiltrating cells like macrophages express iNOS upon
differentiation [49] while losing enzymes for H2O2 production
[50,51] and enriching its scavengers including catalase and
glutathione peroxidase [52].
Quantitative evidence of the ‘‘two hit’’ mechanisms
is provided by comparison of two animal models:
functional ischemia model in mdx mice vs. severe
ischemia model in control mice
The quantitative comparison of control and mdx mice showed that
inhibition of NO/EDHF alone caused functional ischemia
comparable to that of mdx mice (Figure 6), but did not induce
muscle cell death to the same extent as was seen in mdx mice. To
induce contraction-dependent myofiber damage in control mice to
the comparable extent of that of mdx mice, a more severe ischemia
and more strenuous tetanic stimuli were necessary (Figure 5 and
6). These results suggest that independent of abnormal blood flow
response, myofibers in mdx mice are already vulnerable to
mechanical stress. Our experiments have demonstrated the
existence of at least two causes leading to contraction-induced
myofiber damage in mdx mice: (i) a pharmacologically treatable
factor (RBC flux), which is mediated by NO/EDHF and possibly
other molecules, and (ii) elements independent of NO/EDHF or
blood flow regulation (supporting information Figure S8a–d).
These two factors may explain the previously suggested ‘‘two-hit’’
mechanism in this disease [23]. Neither one of these two factors
alone causes muscle damage to the level observed in mdx mice.
Only when the above two factors are affected (‘‘hit’’) at the
molecular or pathophysiological level, does the muscle develop
significant amount of damage.
Despite the result showing that inhibition of only NO
production is not enough to cause cell death (Figure 5), it is
intriguing that addition of SNAP (an NO donor) can prevent
contraction-induced cell death (Figure 4). Perhaps mammals have
evolved so that there are redundant factors provided for muscle
contraction-induced blood flow increase and protection from
contraction-induced stress. Thus, even if EDHF synthesis/function
fails, another factor such as NO may substitute in its absence and
vice versa. Replenishing NO can, by itself, normalize the blood
flow and prevent ischemia-induced injury despite the possibility
that the affected muscles are still inherently susceptible to
contraction-induced damage.
PDE5 Inhibitors can be a potential therapeutic agent
to treat DMD
Additional support linking vasoregulation to the cause of muscular
dystrophy was demonstrated by the effective treatment of the mdx
Figure 6. Comparison of total RBC flux increase in control and mdx mice in response to tetanic stimulation and pharmacological agents. Total
RBC flux increase was calculated as an integral of % change in RBC flux after stimulation. Tetanic stimulation increased the flux to 653.2 (%6min, far
left column) in control mice. Administration of L-NAME (2nd column), apamin plus charybdotoxin (3rd), or vascular oppression (5th) suppressed the
increase in RBC flux. When all the above treatments were combined, RBC flux was further suppressed (6th). The level of ischemia in the control mice
receiving all the combination (6th) was more severe as compared to mdx mice (far right). N=8 mice, for each treatment. * and **: Statistically
significant difference from all other treatments (p,0.05 and 0.01, ANOVA). ##: Statistically significant difference between the two groups (p,0.01, t-
test). Standard error bars are added to the histogram.
doi:10.1371/journal.pone.0000806.g006
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the experimentsfromin vivo microscopyshowingthe essentialroleof
functional ischemia in the pathogenesis of muscular dystrophy, and
itis expected that thisdrug aswell asothervasoregulatory molecules
can be a future therapeutic target of this disease. Although
vasoactive agents (NO, 8CPT-cGMP, and clenbuterol) almost
completely prevented myofiber damage in our short-term experi-
ments from in vivo microscopy (Figure 4), there was still remaining
myofiber damage observed in some animals treated with tadalafil
(Figure 7a and 7b). This may be due to a downregulation of the
effect of the drug after weeks of treatment, or because of possible
variations in the extent of ad lib movements of individual animals
that will require further investigation. In this study, we prioritized
biological question about the efficacy of tadalafil and started the
drug treatment before birth and continued during lactation and
weaning until 4 weeks of age, based on the fact that myofiber
damage in always upregulated in mdx mice and DMD patients even
before birth [53,54] and that this drug has high transplacental
distributioncapabilityandislactationallysecreted[55].Biologically,
our data from experiments in tadalafil treatment supports that
histological changes are due to the increased turnover of muscle
degeneration and regeneration. The numbers of myofibers with
central nuclei, characteristic of active regeneration was reduced by
tadalafil treatment. This observation suggests that PDE5I can
ameliorate the progress of the disease mainly through its myofiber
protective function, but not through upregulation of regeneration
Figure 7. Evans Blue staining of the damaged fibers in the hindlimb and the diaphragm muscles of mdx mice (4 weeks old). (a&b) Six hours after
the injection of Evans Blue dye, the extent of myofiber damage as indicated by blue staining was observed in the superficial hindlimb muscles (a) and
the diaphragm (b). Three mice from each group are shown (a and b). Compare lateral and medial views of the stained fibers (arrows) in mice without
(2) and with (+) tadalafil treatment (a). Mice without tadalafil treatment (2) show extensive blue staining (arrows in a and b). Tadalafil treatment (+)
ameliorated the damage in the same muscle tissues, although it did not completely suppress the myofiber damage in some mdx mice. (c)
Gastrocnemius, gluteus maximus, quadriceps, and diaphragm muscles were harvested and cryosectioned for fluorescence microscopic observation.
In the non-treated group (Mdx#1 and #2 in c), all the muscles studied showed increased numbers of damaged myofibers stained by the injected dye
(high fluorescence signals are shown in white). Tadalafil treatment reduced the numbers of damaged myofibers (Mdx#3 and #4 in c). The white
scale bar at the bottom of images represents 100 mm for gastrocnemius, gluteus, and quadriceps, and 50 mm for diaphragm. (d) The number of
positively stained damaged myofibers (in c) were counted and shown as bar graphs for the entire gastrocnemius, gluteus, and quadriceps muscles.
For diaphragm muscles, the positively stained myofibers are shown as percentage of the total fiber count. Mdx mice without treatment (N=10, white
columns) showed extensive amount of myofiber damage. Tadalafil treatment (N=8, columns shaded with hatched lines) showed a statistically
significant decrease in the amount of damaged myofibers in gastrocnemius, gluteus maximus, and quadriceps muscles. *: p,0.05, **,p,0.01 by t-
test. N refers to the number of animals used for each treatment.
doi:10.1371/journal.pone.0000806.g007
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occur secondarily to upregulated muscle degeneration. To fully
establish its therapeutic potential of tadalafil treatment, however,
long-term therapeutic study on post-weaning mdx mice is required.
Our data suggest that the myofiber protective effect of cGMP in
the acute phase experiment is likely through its vascular role, but
do not exclude the possibility that the NO-cGMP pathway exerts
anabolic effect through a non-vascular mechanism in more
chronic way. More specific experiments with molecular biological
interventions are in progress to further examine the pathophys-
iology of DMD and test the long-term efficacy of PDE5I on adult
mdx mice. Furthermore, our conclusion of the primary role of
vascular role in the pathogenesis of muscular dystrophy does not
deny or exclude the possibility of the currently accepted theory of
‘‘membrane vulnerability’’. In fact, membrane vulnerability may
be the other factor of the ‘‘two-hit’’ mechanism.
Conclusion
In summary, we have documented strong evidence for the primary
role of functional ischemia in the pathogenesis of muscular
dystrophy. We have for the first time quantitatively demonstrated
the existence of the ‘‘two-hit’’ mechanism in this disease.
Importantly, a promising therapeutic approach was demonstrated
with a vasoactive drug.
Figure 8. Evaluation of the efficacy of tadalafil by conventional histology. (a) Two images from different animals in tadalafil-treated and non-
treated groups are presented for trichrome staining of gastrocnemius muscles (left panels): Ectopic fibrosis in extensively damaged areas was
observed in the non-treated group (2) (yellow arrows). In the treatment group (+), there are still damaged fibers and ectopic fibrosis observed, but
not to the level seen in the non-treated group. In H&E staining of gastrocnemius muscles (right panels), non-treated mdx mice showed many
basophilic (purple) small cells reminiscent of infiltrating cells, proliferating fibroblasts/myoblasts, and tadalafil-treated group showed less. Myofibers
with central nuclei, suggestive of regenerating fibers, are basophilic and prominent in the non-treated group, but were also observed in the treated
group. Heterogeneity of fiber size was more prominent in the non-treated group. Yellow diamond arrows with ‘‘C’’ point to myofibers with central
nuclei. Black scale bars on each micrograph image represent 50 mm. (b) The area size for ectopic fibrosis with blue staining was calculated in pixel size
(n=6 and 5 for non-treatment and tadalafil treatment groups). Tadalafil significantly reduced the amount of fibrosis in gastrocnemius (GC), gluteus
(Glut), quadriceps (Quad), and diaphragm (Diaph) muscles (*: p,0.05 by t-test). (c) The percentage of myofibers with central nuclei is shown in
a histogram. Tadalafil treatment reduced the percentage of central nuclei (*:p,0.05, **:p,0.01 by t-test) (d) The variation in fiber size in
gastrocnemius muscles was quantified and shown as percentage fiber distribution. In non-treated mdx mice, the fiber size was uneven ranging from
small (,300 mm
2) to large (.2800 mm
2) cross sectional area. Tadalafil treatment reduced the variation by lowering the percentage of small myofibers
(*: p,0.05 by t-test)
doi:10.1371/journal.pone.0000806.g008
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Reagents
Krebs Ringer (‘‘KR’’, d-glucose 1.8 g/l, MgCl2 46.8 mg/l, KCl
340 mg/l, NaCl 7 g/l, Na2HPO4 100 mg/l, NaH2PO4 180 mg/l,
NaHCO3 1.26g/l, pH=7.30), and PBS (phosphate buffered
saline, NaCl 8 g/l, KCl 200 mg/l, Na2HPO4 1.44 g/l, KH2PO4
240 mg/l, pH=7.4) were prepared fresh and pH adjusted for
each experiment. L-NAME (Sigma, Nv-Nitro-L-arginine methyl
ester, 1 mg/ml), charybdotoxin (Sigma, 0.1 mM), apamin (Sigma,
1 mM), a-bungarotoxin (Invitrogen, 1 mg/ml), DiOC6 (3,39-
dihexyloxacarbocyanine iodide, Invitrogen, 80 nM), Annexin-V
AlexaFluor 350 (Invitrogen), SNAP (Sigma, S-nitroso-N-acetylpe-
nicillamine, 100 mM), 8-(4-chlorophenylthio)-guanosine 39,5 9-
cyclic monophosphate (8-CPT cGMP, Sigma, 500 mM), clenbu-
terol (Sigma, 0.05 mg/ml), and angiotensin-II (Sigma, 1 mg/ml)
were applied in KR as a vehicle. Evans Blue dye (Sigma, 5 ml/
gBW of 10 mg/ml solution in PBS) and tadalafil (Eli Lily and
Company, 1 mg/100 ml water) were used for PDE5I experiments.
Mouse Strains and in Vivo Microscopic Observation
of Skeletal Muscles
An mdx mouse colony was established by mating hemizygote male
and homozygote female of mdx strain (C57BL/10ScSn-Dmd
mdx/J)
purchased from Jackson Laboratories. Control mice were inbred
C57BL/10ScSn. Adult male mice between the age of 3 months and
6 months were used in this study except for the PDE5I
experiment. A previous study that showed DMD involves
a pathologic change of sternocleidomastoid muscles in humans
[56] was the basis for our experiments to investigate the
pathophysiological changes in the corresponding mouse sterno-
mastoid muscle. All the procedures related to animal experiments
were reviewed and approved by the Subcommittee on Research
Animal Care of Massachusetts General Hospital. We followed Jeff
W. Lichtman’s method [57] with modifications. Mice were
anesthetized by intraperitoneal injection of pentobarbital
(50 mg/kgBW), shaved on the front neck, intubated with a 20
gage polyethylene tube, mechanically ventilated, and warmed at
37uC on a Kapton sheet heater. The right and left sternomastoid
muscles were exposed aseptically and superfused with sterile Krebs
Ringer. Water-dipping objective lenses were utilized for live
epifluorescent observation. An intensified SIT Camera (Hama-
matsu Photonics, C2400) was installed on a Nikon Eclipse-800
microscope to capture the low-intensity signal at the real-time
video rate (30fps). A conventional CCD Camera (SPOT,
Diagnostics Instruments, Inc.) allowed documentation of high
resolution fluorescence images. Fluorophores and the filter sets
utilized were DiOC6 (484/501 nm for excitation/emission
hereafter), Hoechst 33258, (352/461), Propidium Iodine (536/
617), and Alexa Fluor 594-conjugated a-bungarotoxin (590/617).
An automated z-axis focusing system (Prior, Proscan II) was used
for acquiring images on focus planes at different depth. To obtain
qualitative morphological documentation, two-dimensional pic-
tures were derived from stacks of photographs by extracting in-
focus information from z-axis planes to create image mosaics by
MetaMorph (Molecular Devices). Quantitative analyses for
fluorescence intensity were performed on single images documen-
ted using the CCD camera.
Muscle Stimulation
An electrical pulse was generated using a Peripheral Nerve
Stimulator (Innervator 252, Fisher&Paykel Healthcare), and
delivered to the muscle surface via a coated stainless probe at
supramaximum condition (see supporting information, Figure S2).
A minus probe end (ground) was placed on the proximal part of
muscle and a plus end (source) was placed on the distal muscle
area. The experimental design is based on either a single train of
stimuli (5 seconds of 50Hz, for RBC flux experiment), or a series of
trains of stimuli (a repeated pattern of 5 seconds of 50Hz with 30-
second intervals, for NO/H2O2 production, cell death experi-
ments). The electrical current did not cause direct damage on the
vicinity of contact area. Pharmacological reagents at physiological
concentrations described above were applied directly to the area.
Blood Flow Analysis
Labeling RBCs and Injection Mouse RBCs, prepared from
the inbred allogenic mice with heparinization, were washed in
KR, and incubated with 2 mM PKH26GL (Sigma) for 5min at
room temperature. After staining, the remaining dye was
quenched with heat-inactivated serum, and washed away with
KR. A bolus of 50 ml of a 12% haematocrit of the stained RBCs
diluted in 37uC KR was injected into the penile vein. Using in vivo
microscopy, video images of the circulating fluorescent-labeled
RBCs (551/567 nm) were recorded on a DVD through the SIT
video camera at 30 frames per second at the level of primary
arterioles (Strahler’s numbering system: see supporting
information, Figure S1) [58]. No hemolytic response due to
transfusion was observed during the time of observation up to
6 hours. After injection of the stained RBCs, animals were kept
quiet and stable for 30 minutes. The average baseline RBC flux
was recorded and calculated from 5 minutes’ flux measurement.
Reagents were applied at this point. A 10 minute recording was
made after muscle contraction by one tetanic stimulus as described
above. At the end of the experiment, mouse whole blood was
obtained from the heart. The whole RBC concentration and the
ratio of stained/non-stained RBCs were counted using
a hematocytometer.
Analyses of RBC Flux Recorded DVD video images were
transferred to Video Savant
TM image files through a frame
grabber (MV-1000, MuTech). Video images were reviewed on
a monitor in adjusted speed in order to visualize individual stained
RBCs. RBC flux was measured by counting labeled RBCs flowing
through a focused primary arteriole per minute. One arteriole per
mouse was selected from NMJ or non-NMJ area. The absolute
numbers of RBC flux was calculated from the ratio of stained/
non-stained RBCs. The total increase of RBC flux (for Figure 6)
was calculated as the integral of the percent increase of RBC flux,
or the area size of the area bound between the curve of RBC flux
and basal line (100 percent line), shown as the green area
subtracted by red area in the supporting information, Figure S6.
Vascular Oppression To impose a severe ischemic stress on
the muscle, vascular oppression was applied from backside (dorsal
side) by pressing the muscle with 10 g force using a smooth double-
rod of a 0.3 mm diameter. The applied force of 10g was measured
by a force-displacement transducer (FT03C, Grass Instruments)
connected to an AC/DC strain gage amplifier (P122, Grass
Instruments) and recorded by a computer software (‘‘Polyview’’,
GrassInstruments).Thismanipulationdidnotcauseanydetrimental
effect by itself or in combination with tetanic stimulation (see above for
results and Figure 5). Measurement of RBC flux under this condition
confirmed the decreased blood flow but not a complete blood vessel
obstruction (see above for results and Figure 6).
Measurement of In Vivo NO and H2O2 Production
The membrane permeable dye for nitric oxide (NO) detection,
DAF-FM (4-amino-5-methylamino-29,79-difluorofluorescein, Invi-
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sternomastoid muscle and incubated for 15 minutes at 37uC.
DAF-FM becomes fluorescent (excitation 495 nm, emission
515 nm) when it couples with NO in physiological conditions.
Baseline fluorescence intensity was measured before the muscle
stimulation. Five second tetanic stimuli were given to the muscle
6 times with 30 seconds intervals. After the stimulation, an in vivo
fluorescence signal was acquired repeatedly every 10 minutes
with a CCD camera and analyzed by an image software
(MetaMorph, Molecular Devices). Fluorescent intensity was
quantified by densitometry of the captured images using
a standard fluorescent-intensity curve. Photo-activation and
photo-bleaching of dye were avoided by limiting the exposure
time to less than 1 second and using appropriate ND filters. For
measurement of in vivo H2O2 production, membrane permeable
carboxy-H2-DCFDA (29,79- dichloro- dihydrofluorescein diace-
tate, excitation 493 nm, emission 522 nm, Invitrogen) was
applied at 5 mM and incubated for 15 minutes at 37uC. Five
second tetanic stimuli were given to the muscle 12 times with
30 seconds intervals. Every 20 minutes after stimulation, an in
vivo fluorescence signal was acquired.
Fluorescent light standard Fluorescent microspheres
(LinearFlow
TM Green Flow Cytometry Intensity Calibration Kit,
Molecular Probes, 6 mm for 488 nm excitation/515 nm emission)
were used as the internal standard to normalize the fluorescence
intensity. In order to generate a standard fluorescent-intensity
curve, three different types of microspheres (Component C, D, E;
0.4%, 2%, 10% each, relative intensity of Component F; 100%)
were selected and average fluorescent intensities per pixel were
calculated for each component. Exposure times and gains were
determined in order for each dye to fit within a linear range of this
standard curve and maintained throughout the experiment.
Real-Time In Vivo Monitoring of Muscle Cell Death
Staining and Microscopy Sternomastoid muscles were stained
with a-bungarotoxin (BTX) and DiOC6. Postsynaptic
acetylcholine receptors were labeled with 1 mg/ml of Alexa
Fluor 594-conjugated a-BTX for 10 minutes. According to
previous studies, this dosage did not block postsynaptic activity.
DiOC6 (80nM, 15 min) stains mitochondria and endoplasmic
reticulum (M/ER) only in live cells. At this concentration, DiOC6
staining was not cytotoxic to skeletal muscle cells. DiOC6 yielded
irreversible staining and remained on their specific target until
they were removed by the biological turn-over or underwent
fluorescence bleaching. Thus, documentation of the chronological
alteration in the morphology of neuromuscular junctions (NMJs)
and of organelles was possible. Specific tissue sites were identified
and followed using the shape and location of NMJs as signposts. In
mdx mice, a 5 second tetanic stimulation (TS) was applied 6 times
as described above. In control mice the TS was applied 6 or 12
times and compared. Stained muscles were recorded at
30 minutes, 2 hours, 4 hours and 6 hours after stimulation.
Video images were recorded using an intensified SIT camera at
30 frames per second, recorded on DVD, and the numbers of
dead myofiber loci in the entire muscle were counted manually.
Fiber Loci Counting and Criteria for Myofiber
Damage We counted between 70 and 80 myofibers per scan
for both control and mdx mice. These numbers are similar to but
slightly less than those of fiber counts in the original method on
sternomastoid muscles [59], because we observed the few
superficial layers of the muscles due to the nature of our
staining. To scan the whole area, the microscopic image field
was moved transversely (along x-axis) back and forth, shifting
along y-axis with each scan (supporting information, Figure S4a).
For the feasibility of counting, fibers in different image fields of
observation were regarded as different. Thus, scan #1 (supporting
information, Figure S4a) counted fibers from 1 to 70, scan #2
counted from 71 to 140, and so forth. The grand total numbers of
counted fibers of 350 to 400 (70 to 80 multiplied by the numbers of
5 transverse scan) covered the actual area size of approximately
10 mm
2 and were consistent throughout the experiment, both for
control and for mdx mice. Because of the anatomical structure of
the sternomastoid muscle, the distal (mastoid) end of the muscle
tissue was not counted. Granulated, rippled, or bulged cluster of
staining with DiOC6 were considered as criteria to define
abnormal distribution of M/ER of damaged fibers. Myofibers
manifesting any of these traits eventually led to regional cell death,
as detected by the dye exclusion staining method using propidium
iodide (1 mg/ml, 15 min) or Hoechst 33258 (2 mg/ml, 3 min) and
Annexin-V AlexaFluor 350 staining (30 min). By our criteria,
granular, rippled, and bulged areas within a single fiber were
counted as one damaged myofiber locus as long as the lesion was
continuous (supporting information, Figure S4b). If any two lesions
were separated by an intact area with a normally striated pattern
extending into different field of observation, those were counted
separately. If two lesions were not continuous, and were separated
by an area where staining was completely lost, or the fiber was
severed, resulting in different fields of observation, those were
regarded as different loci.
Tadalafil Treatment and Evans Blue Assay
To achieve oral administration of tadalafil, mdx mice were treated
with 1mg tadalafil/100 ml drinking water from the beginning of
pregnancy. The drug containing water was changed twice per
week. For histological detection of damaged myofibers, we
followed a previously described method [60] with a minor
modification. At 4 weeks after birth, Evans Blue dye was injected
intraperitoneally (50 mg/gBW in PBS) to detect and quantify the
amount of damaged myofibers. After 6 hours, mice were sacrificed
and skeletal muscle tissues harvested. Muscles were pin-stretched
and frozen in OCT (Tissue-Tek) at 280uC. The harvested
muscles were cryosectioned at 7 mm, acetone fixed for 10 minutes
at 220uC, and observed under fluorescence microscopy (540/
610nm).
Trichrome and Hematoxylin-Eosin (H&E) Staining
Mdx mice are anesthetized, heparinized, blood removed and
perfuse-fixed by cardiac injection of 4% paraformaldehyde (PFA)
freshly prepared in PBS. Hindlimb muscles (gastrocnemius,
quadriceps, and gluteus) were harvested and further fixed by
immersing in 4% PFA in PBS for 24 hours before being
embedded in paraffin and sectioned at 4 mm thickness using
a rotary microtome (Leica). Sections were stained by standard
hematoxylin-eosin (H&E) and trichrome staining.methods. Briefly,
for H&E staining, deparaffinized and hydrated sections were
treated in Harris-modified hematoxylin with acetic acid solution
(Fisher), washed in water and counterstained with saturated eosin-
Y solution (Richard Allan Scientific) for 2 minutes respectively.
For Masson trichrome staining, the sections were stained by
following the manufacturer’s instructions (Sigma). Ectopic fibrosis
was determined by the specific blue color deposition from
trichrome staining followed by image analysis with Metamorph
on cross sections (gastrocnemius, gluteus, quadriceps) or longitu-
dinal sections (diaphragm). We excluded areas for tendons, normal
epimysiums, perimysiums and endomysiums as well as meta-
chromatic myofibers (presumably unhealthy myofibers). 10 to 20
random areas are chosen from 3 different sections. Pixel count for
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averaging the values obtained. The cross sectional area size (mm
2)
was measured on H&E stained images by Metamorph and the
distribution of fiber percentage was calculated. The numbers of
myofibers with central nuclei are counted based on H&E staining
of cross-section (gastrocnemius, gluteus, and quadriceps). In-
filtrating cells and satellite cells are excluded.
Statistics
The normality of the data was evaluated by the Kolmogorov-
Smirnov test. The comparison of means was performed with one-
way ANOVA or t-test for multiple/two group comparisons. The
increment from basal level in blood flow or cell death was assessed
by one-way repeated measures ANOVA. Medians were also
compared by Mann-Whitney U test. For all tests significance was
accepted when P,0.05.
SUPPORTING INFORMATION
Figure S1 Schematic drawing of arteries, arterioles, venules and
veins running through the right sternomastoid muscle of mice
(equivalent of the medial part of the sternocleidomastoid muscle in
humans). The drawings of 1u (primary) arterioles and capillaries
are omitted for simplification. The measurement was made at
locations enriched with neuromuscular junctions (shown as
‘‘NMJs’’) and non-neuromuscular junctional areas (shown as
‘‘A’’, ‘‘B’’, and ‘‘C’’). Nomenclature based on Strahler [58].
Found at: doi:10.1371/journal.pone.0000806.s001 (2.27 MB TIF)
Figure S2 Comparison of muscle contractile force generated by
50Hz tetanic stimulation. Contractile force by the sternomastoid
muscle was compared between control and mdx mice. Bipolar
supramaximal electrical stimulation (20% beyond the voltage
yielding maximal contractile force) was given directly onto
sternomastoid muscles. The head of the mice was fixed by
pinching the mastoid portion of the temporal bone. After the
preload of 5 gram was stabilized, the tension force was measured
by a transducer ligated to the sternum. Train of four (TOF, 2Hz)
and tetanic stimulation (50Hz) were given. The left graph shows
the kinetic of force generation (gram) plotted against time
(seconds). Each color represents different animals. The maximum
force generated by tetanic stimulation was not statistically different
between control and mdx mice (right side bar graph). Standard
errors are attached to the bar graph. ‘‘n.s.’’ stands for not
statistically significant (Student-t, p=0.60)
Found at: doi:10.1371/journal.pone.0000806.s002 (6.54 MB TIF)
Figure S3 Confirmation of damaged fiber detection methods
Sternomastoid myofibers are induced to cell death by the same
stimulation used in Figure 5. Three different areas are shown.
Healthy fibers with normal striated pattern of DiOC6 staining
(fiber#1&3) are void of stating by propidium iodide (PI, red) or
Annexin-V (blue). Damaged fiber loci (fiber#2,4,5&6) according
to the criteria shown in Figure S4 are also stained by PI and
Annexin, confirming fiber death.
Found at: doi:10.1371/journal.pone.0000806.s003 (10.41 MB
TIF)
Figure S4 Method for counting the damaged myofiber loci.
Scanning procedure is shown in (a). The image field on the
microscope was moved transversely (x-axis) starting from the head
side (mastoid). After each scan, the field of view was shifted along
the y-axis towards the chest side (sternum) to avoid overlap with
the previous scan. This process was repeated five times to cover
the entire sternomastoid muscle. Because of the anatomical
structure of the muscle, the extreme end of the muscle on the
head side (mastoid) was not visualized. (b) Criteria for counting the
damaged myofiber loci are shown in (b). DiOC6 staining of muscle
organelles (M/ER) with rippled, bulged, or granular pattern were
considered damaged myofibers that eventually will lead to local
cell death. If any two or three of these patterns were found in
a single myofiber, those are counted as one damaged locus, as long
as the lesion was continuous ((i) Continuous lesion). Some
myofibers were affected by damages of multiple onsets. If any
two lesions were separated by an intact area with normal striated
pattern of M/ER extending into another field of view, those were
counted as two loci ((ii) Multiple onset). If any two lesions were
discontinuous, separated by loss of fiber staining or severing and
isolated into different field of view, those were counted as two ((iii)
Discontinuous).
Found at: doi:10.1371/journal.pone.0000806.s004 (4.86 MB TIF)
Figure S5 Microscopic images of myofibers from mdx mice after
tetanic stimulation with our without SNAP treatment and from
control mice receiving tetanic stimulation and varying degree of
ischemic stress. Fluorescence images of chronological changes in the
morphology of intact and dying cells in the mdx mice are shown
(400x, black scale bars at the bottom of images represent 10 mm).
The NMJs were stained with red fluorescence as signposts to detect
individual fibers. Mitochondria and endoplasmic reticulum (M/ER)
of sternomastoid muscles were stained by DiOC6. Clusters of these
stained M/ER form a transverse striated pattern in the normal
intact myofibers (green staining at 30 minutes). (a) In mdx mice,
repeated tetanic stimuli (5 second stimulus at 50Hz, repeated 6
times with a 30 seconds interval) caused dying myofibers with an
abnormal distribution of the DiOC6-stained components (a, Row1,
Mdx+tetanic stimuli). At 4 hours, the M/ER showed a granular
pattern of distribution in the damaged fiber loci (arrow heads). At
6 hours, those granular staining areas changed into a larger cluster
of bright fluorescent spots to form a bulged structure (arrows).
Administration of SNAP (NO donor, 100 mM) prevented the mdx
micefibers fromundergoing contraction-induceddamage (a,Row2,
Mdx+tetanic stimuli+SNAP). (b) When L-NAME, apamin plus
charybdotoxin, vascular oppression were all combined, tetanic
stimulationcausedmyofiber damage incontrol mice(b, Row3).At 2
to 4 hours after stimulation, damaged myofibers exhibited a gran-
ular distribution pattern (arrow heads). Eventually, those damaged
fibers showed bulged staining (arrows). When any of the following
treatment was absent, myofiber damage did not occur to the similar
extent seen in the group described above: L-NAME (b, Row4),
apamin plus charybdotoxin (Row5), vascular oppression (b, Row6),
tetanic stimulation (b, Row7). Tetanic stimulation and vascular
oppression alone did not cause damage (b, Row8). Normal pretzel-
like NMJ morphology in control mice (b, red staining) did not
change into the abnormal fragmented shape seen in mdx mice (a) or
vice versa, by any combinationof treatments during the observation
period.
Found at: doi:10.1371/journal.pone.0000806.s005 (9.50 MB TIF)
Figure S6 Calculation of the total increase of RBC flux. Total
increase of RBC flux is given by the integral of the curve from 0 to
10 minutes after tetanic stimulation for the percent from basal
RBC flux. The formula is provided as F(n)+1/2F(10): from n=1 to
9, where F(n) stands for RBC flux (%) minus 100 at time n
(minute). Note that a complete embolization of arteries will
theoretically result in the value of negative 950.
Found at: doi:10.1371/journal.pone.0000806.s006 (2.37 MB TIF)
Figure S7 Illustration of functional ischemia by a conventional
(macroscopic) and by a new (microscopic) approach. Contracting
skeletal muscles require an increased blood flow to meet metabolic
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normal response is disturbed. (a) In order to observe functional
ischemia, the previous studies measuring crude macroscopic blood
flow required the muscles to be put under vasoconstrictive stress by
sympathetic stimulants. Skeletal muscle contraction reverts the
drop in the crude blood flow in normal muscles (a normal response
of sympatholysis). Sympatholysis is absent in the affected muscles
where normal vascular regulation mechanisms are lacking. Thus,
normal muscles are rescued from ischemia by sympathetic
vasoconstriction when superimposed by contractile stress but
diseased muscles are put under the risk of continued ischemia. (b)
In our new microscopic study, preloading with vasoconstrictive
stress is unnecessary to observe functional ischemia. RBC flux
increases after muscle contraction in normal subjects. This
increase in RBC flux is perturbed in mdx mice. One of the
technical advantages in analyzing RBC flux is to reveal a functional
ischemia by a simpler scheme of stimulation than previous
macroscopic studies. This observation is reasonable considering
our understanding that the crude macroscopic blood flow
measurement does not necessarily reflect peripheral (microscopic)
RBC flux [61]. Note that RBC flux, RBC velocity, and vascular
diameter are different parameters of microcirculation and may
follow different kinetics, though all of these are important factors
determining the state of local blood flow. We emphasize the
importance of measuring the RBC flux in this type of analysis.
Found at: doi:10.1371/journal.pone.0000806.s007 (2.57 MB TIF)
Figure S8 The relationship between functional ischemia and
myofiber damage in control and mdx mouse models. (a) Normal
blood flow response vs. lack of response in mdx mice. The results
from our experiments in control and mdx mice supports the
hypothesis that RBC flux in control mouse increases in response to
muscle contraction via increased production of NO and H2O2,
and mdx mice are deficient of NO and H2O2 production in
response to muscle contraction resulting in functional ischemia
and the risk for myofiber damage. (b) Quantitative analysis
between the extent of functional ischemia and myofiber damage
suggests that there are at least two major factors causing the
contraction-induced myofiber damage in mdx mice: (1) functional
ischemia, which is likely to be caused by the lack of NO/H2O2
production, and (2) a putative intrinsic factor which makes mdx
myofibers inherently more vulnerable than those in control mice,
independent of NO/H2O2 regulation. (c) Mdx mice under
pharmacotherapy against functional ischemia are still inflicted by
inherent weakness, but myofiber damage can be prevented. (d)
Control mice inflicted with artificial ischemia do not show
comparable amount of myofiber damage, because their myofibers
are not inherently weak.
Found at: doi:10.1371/journal.pone.0000806.s008 (4.16 MB TIF)
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